Figure 3From: Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept®, Roche): overviewInduction of LacZ mutations in bone marrow after single dose and 4-week chronic dosing with EMS and ENU (effects plotted against the cumulative dose).Back to article page